PT-141 (Bremelanotide) · Physician Directory

    PT-141 (Bremelanotide) in Austin, TX

    Patients searching for PT-141 (Bremelanotide) in Austin, TX are typically weighing three things: which licensed providers will prescribe it, whether telehealth is an option, and what the published evidence actually shows. This page covers all three.

    Austin's health-conscious community has fueled rapid growth in peptide therapy clinics across the city. Integrative and functional medicine providers offer protocols for metabolic health, tissue repair, and performance optimization.

    About PT-141 (Bremelanotide): PT-141 (Bremelanotide) is an FDA-approved melanocortin receptor agonist indicated for hypoactive sexual desire disorder in premenopausal women (Vyleesi). It acts on MC3 and MC4 receptors in the central nervous system to modulate sexual arousal. It is distinct from PDE5 inhibitors in its mechanism of action.

    0 results

    Sample profiles shown

    Be the first physician listed for PT-141 (Bremelanotide) in your area.

    Claim your listing

    Austin, TX · Patient Questions

    PT-141 (Bremelanotide) in Austin: what patients ask

    Can I get PT-141 (Bremelanotide) in Austin?
    Access to PT-141 (Bremelanotide) in Austin, TX depends on the prescriber's clinical judgment and the compound's regulatory status. Some peptides are available through TX-licensed physicians via in-person visits or telehealth; others are restricted to research settings. Always verify your provider's license and ask how they source the compound.
    Is PT-141 (Bremelanotide) legal in TX?
    PT-141 (Bremelanotide)'s legal status follows federal FDA classification rather than state-specific rules. Most peptides discussed on TruthTides are not FDA-approved for general prescribing — they're available through compounding pharmacies under 503A/503B pathways, through licensed physicians for research, or restricted entirely. A TX provider can explain what's allowed for your situation.
    What should I ask a Austin provider about PT-141 (Bremelanotide)?
    Ask: (1) What evidence supports using PT-141 (Bremelanotide) for my specific condition? (2) Is the compound sourced from a 503A or 503B compounding pharmacy? (3) What monitoring will you do during treatment? (4) What are the known risks and gaps in the research? (5) Is this covered by insurance, and what is the cash price?
    Is telehealth available for PT-141 (Bremelanotide) in Austin?
    Yes — many TX-licensed providers offer PT-141 (Bremelanotide) consultations via telehealth, including initial evaluations, follow-ups, and refills. Telehealth is often the most accessible path for residents outside major metro areas. Confirm the provider holds an active TX medical license before booking.

    Educational information only. Not medical advice. Confirm any provider's TX medical license at the TX medical board before booking.

    PT-141 (Bremelanotide) · Clinical Reference

    Frequently Asked Questions

    Is PT-141 safe?

    PT-141 (Bremelanotide) has been evaluated in FDA registration trials for hypoactive sexual desire disorder. Common side effects include nausea, flushing, and headache. A transient increase in blood pressure has been observed.

    It is not recommended for patients with uncontrolled hypertension or cardiovascular disease. Discuss your medical history with your prescriber.

    What does PT-141 do?

    PT-141 is a melanocortin receptor agonist that acts on MC3 and MC4 receptors in the central nervous system to modulate sexual desire and arousal. Unlike PDE5 inhibitors (e.g., Viagra), it works through neurological pathways rather than vascular mechanisms.

    It is the only FDA-approved treatment that targets sexual desire directly.

    How is PT-141 administered?

    The FDA-approved form (Vyleesi) is administered via subcutaneous injection in the abdomen or thigh at least 45 minutes before anticipated sexual activity. Use is limited to once within 24 hours and no more than 8 doses per month.

    Compounded versions may follow different protocols as directed by a prescriber.

    Is PT-141 FDA-approved?

    Yes. PT-141 is FDA-approved under the brand name Vyleesi for the treatment of hypoactive sexual desire disorder (HSDD) in premenopausal women.

    Compounded versions are also available for off-label use in both men and women through licensed pharmacies.

    What conditions is PT-141 used for?

    The FDA-approved indication is HSDD in premenopausal women. Off-label use includes sexual dysfunction in men (particularly those who do not respond to PDE5 inhibitors) and general libido enhancement.

    Research continues into additional applications involving melanocortin receptor modulation.

    How long does PT-141 take to work?

    PT-141 typically takes effect within 45 minutes to 2 hours after injection. Effects can last up to 12–24 hours.

    It is used on an as-needed basis rather than as a daily maintenance medication.

    Can I get PT-141 without a prescription?

    No. PT-141 requires a prescription in all forms — both the branded Vyleesi product and compounded versions. It must be obtained through a licensed pharmacy.

    How do I find a doctor who prescribes PT-141?

    TruthTides maintains a directory of licensed prescribers experienced with clinically relevant peptides. Search by location, telehealth availability, and peptide expertise to find a qualified provider near you.

    Find a prescriber near you →